News & Views

Adobestock 550344920

Iksuda enters license agreement with University of Goettingen

Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates

Adobestock 427889993

Forging stable relationships for Antibody-Drug Conjugates

DCs are a class of biopharmaceuticals that target cancer cells while leaving healthy cells alone.

Sign up for more news

Thank you
*required field
*required field
*required field
I confirm that I have read the data protection and Privacy Policy and that I agree to the processing of my personal data